Company Filing History:
Years Active: 2015
Title: Innovations in Analgesics: The Contributions of Inventor Caiqin Yue
Introduction
Caiqin Yue, a notable inventor based in Beijing, China, has made significant contributions to the field of pharmaceuticals, specifically in the development of new analgesic compounds. His innovative research focuses on quaternary ammonium salt compounds, which are designed to provide effective pain relief without the addictive side effects commonly associated with traditional analgesics.
Latest Patents
Caiqin Yue holds a patent for "Quaternary ammonium salt compounds of spirocyclopiperazines, preparation methods and uses thereof." This patent encompasses compounds represented by a specific general formula that includes their stereoisomers, tautomers, derivatives, prodrugs, or pharmaceutically acceptable salts. The patented compounds are useful as muscarine receptor (M-receptor) and nicotine acetylcholine receptor (N-receptor) agonists or antagonists. They offer a promising analgesic effect, providing an effective alternative without the risk of addiction.
Career Highlights
Caiqin Yue's work is currently affiliated with Peking University, where he contributes to innovative research aimed at improving medical treatments. With a keen focus on the synthesis and application of piperazine derivatives, his work is shaping advancements in pharmacology and pain management.
Collaborations
Throughout his career, Caiqin Yue has collaborated with esteemed colleagues, including Runtao Li and Qi Sun. These partnerships in research and development have fostered a collaborative environment that enhances the innovative potential of their projects and findings in the realm of pharmaceuticals.
Conclusion
Caiqin Yue's pioneering work in developing new analgesic compounds marks a significant advancement in pharmaceutical innovation. His contributions not only demonstrate the potential of spirocyclopiperazine derivatives but also hold promise for safer pain management solutions. As he continues his research at Peking University, the medical community looks forward to future breakthroughs that may stem from his innovative approach to analgesic development.